Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2109 | 2017 |
Global burden of primary liver cancer in 2020 and predictions to 2040 H Rumgay, M Arnold, J Ferlay, O Lesi, CJ Cabasag, J Vignat, ... Journal of hepatology 77 (6), 1598-1606, 2022 | 721 | 2022 |
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, ... The lancet Gastroenterology & hepatology 4 (2), 135-184, 2019 | 491 | 2019 |
Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets CW Spearman, M Afihene, R Ally, B Apica, Y Awuku, L Cunha, ... The lancet gastroenterology & hepatology 2 (12), 900-909, 2017 | 318 | 2017 |
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international … I Roberts, H Shakur-Still, A Afolabi, A Akere, M Arribas, A Brenner, ... The Lancet 395 (10241), 1927-1936, 2020 | 314 | 2020 |
The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa GD Kirk, OA Lesi, M Mendy, AO Akano, O Sam, JJ Goedert, P Hainaut, ... Hepatology 39 (1), 211-219, 2004 | 250 | 2004 |
Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium JD Yang, EA Mohamed, AOA Aziz, HI Shousha, MB Hashem, MM Nabeel, ... The lancet Gastroenterology & hepatology 2 (2), 103-111, 2017 | 242 | 2017 |
249ser TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma GD Kirk, OA Lesi, M Mendy, K Szymañska, H Whittle, JJ Goedert, ... Oncogene 24 (38), 5858-5867, 2005 | 205 | 2005 |
Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa ME Mendy, T Welzel, OA Lesi, P Hainaut, AJ Hall, MH Kuniholm, ... Journal of viral hepatitis 17 (2), 115-122, 2010 | 152 | 2010 |
Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity GD Kirk, PC Turner, Y Gong, OA Lesi, M Mendy, JJ Goedert, AJ Hall, ... Cancer Epidemiology Biomarkers & Prevention 14 (2), 373-379, 2005 | 130 | 2005 |
Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030 MW Sonderup, M Afihene, R Ally, B Apica, Y Awuku, L Cunha, ... The Lancet Gastroenterology & Hepatology 2 (12), 910-919, 2017 | 122 | 2017 |
Ser‐249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West Africa K Szymańska, OA Lesi, GD Kirk, O Sam, P Taniere, JY Scoazec, M Mendy, ... International journal of cancer 110 (3), 374-379, 2004 | 117 | 2004 |
Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa MH Kuniholm, OA Lesi, M Mendy, AO Akano, O Sam, AJ Hall, H Whittle, ... Environmental health perspectives 116 (11), 1553-1557, 2008 | 111 | 2008 |
Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review CJ Alberts, GM Clifford, D Georges, F Negro, OA Lesi, YJF Hutin, ... The Lancet Gastroenterology & Hepatology 7 (8), 724-735, 2022 | 98 | 2022 |
Hepatitis B and C virus infection in Nigerian patients with HIV/AIDS OA Lesi, MO Kehinde, DN Oguh, CO Amira Nigerian Postgraduate Medical Journal 14 (2), 129-133, 2007 | 86 | 2007 |
Problem of hepatocellular carcinoma in West Africa NG Ladep, OA Lesi, P Mark, M Lemoine, C Onyekwere, M Afihene, ... World journal of hepatology 6 (11), 783, 2014 | 85 | 2014 |
Osteopontin and latent‐TGF β binding‐protein 2 as potential diagnostic markers for HBV‐related hepatocellular carcinoma AN Da Costa, A Plymoth, D Santos‐Silva, S Ortiz‐Cuaran, S Camey, ... International journal of cancer 136 (1), 172-181, 2015 | 69 | 2015 |
Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The Gambia NJ Umoh, OA Lesi, M Mendy, E Bah, A Akano, H Whittle, P Hainaut, ... Liver International 31 (2), 215-221, 2011 | 67 | 2011 |
Innovative strategies for the elimination of viral hepatitis at a national level: a country case series SE Schröeder, A Pedrana, N Scott, D Wilson, C Kuschel, L Aufegger, ... Liver International 39 (10), 1818-1836, 2019 | 63 | 2019 |
TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia DA Gouas, S Villar, S Ortiz-Cuaran, P Legros, G Ferro, GD Kirk, OA Lesi, ... Carcinogenesis 33 (6), 1219-1224, 2012 | 62 | 2012 |